Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 11, 2024

SELL
$100.18 - $109.02 $65,818 - $71,626
-657 Reduced 0.88%
74,277 $8.1 Million
Q3 2023

Oct 10, 2023

SELL
$102.95 - $114.33 $323,880 - $359,682
-3,146 Reduced 4.03%
74,934 $7.71 Million
Q2 2023

Jul 12, 2023

BUY
$108.61 - $118.38 $56,694 - $61,794
522 Added 0.67%
78,080 $9.01 Million
Q1 2023

Apr 12, 2023

SELL
$102.94 - $114.86 $110,557 - $123,359
-1,074 Reduced 1.37%
77,558 $8.25 Million
Q4 2022

Jan 13, 2023

BUY
$87.44 - $112.11 $394,441 - $505,728
4,511 Added 6.09%
78,632 $0
Q3 2022

Oct 12, 2022

SELL
$84.53 - $94.96 $27,641 - $31,051
-327 Reduced 0.44%
74,121 $6.38 Million
Q2 2022

Jul 13, 2022

BUY
$83.49 - $94.64 $6.19 Million - $7.02 Million
74,188 Added 28533.85%
74,448 $6.79 Million
Q1 2022

Apr 08, 2022

BUY
$73.51 - $82.4 $19,112 - $21,424
260 New
260 $21,000
Q2 2020

Jul 09, 2020

SELL
$70.42 - $80.13 $79,504 - $90,466
-1,129 Closed
0 $0
Q4 2019

Jan 09, 2020

BUY
$77.58 - $87.54 $10,007 - $11,292
129 Added 12.9%
1,129 $103,000
Q3 2019

Oct 07, 2019

BUY
$76.08 - $82.93 $10,803 - $11,776
142 Added 16.55%
1,000 $84,000
Q2 2019

Jul 09, 2019

BUY
$69.84 - $81.59 $9,847 - $11,504
141 Added 19.67%
858 $72,000
Q1 2019

Apr 08, 2019

BUY
$69.58 - $79.36 $4,453 - $5,079
64 Added 9.8%
717 $60,000
Q4 2018

Jan 14, 2019

BUY
$65.24 - $75.71 $27,726 - $32,176
425 Added 186.4%
653 $50,000
Q3 2018

Oct 11, 2018

BUY
$57.69 - $67.84 $13,153 - $15,467
228 New
228 $16,000
Q1 2018

Apr 09, 2018

SELL
$50.96 - $59.23 $407 - $473
-8 Closed
0 $0
Q4 2017

Jan 18, 2018

SELL
$51.62 - $61.64 $12,440 - $14,855
-241 Reduced 96.79%
8 $0
Q3 2017

Oct 12, 2017

BUY
$58.67 - $63.13 $14,608 - $15,719
249
249 $16,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Contravisory Investment Management, Inc. Portfolio

Follow Contravisory Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Contravisory Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Contravisory Investment Management, Inc. with notifications on news.